Loading...
Regulatus has announced the integration of Flinn into its regulatory compliance offering, marking a strategic step toward faster, data-driven decision-making in the evolving medtech landscape.
As global regulations continue to expand in volume and complexity, the need for real-time, reliable intelligence has become critical. Flinn’s AI-powered platform continuously monitors regulatory updates, from ISO standards and guidance documents to industry developments, delivering tailored insights relevant to specific products, markets, and compliance priorities.
By embedding Flinn into its internal processes, Regulatus is enhancing its ability to validate information, streamline technical documentation, and accelerate project delivery without compromising compliance. Early adoption has already reduced the time required to prepare key documents such as Clinical Evaluation Reports (CERs).
Beyond internal use, Regulatus is now offering Flinn as a supported service to clients, combining AI-driven insights with expert regulatory interpretation. This enables companies to respond more quickly to change, while maintaining confidence in their compliance strategies.
The move reflects a wider industry shift toward intelligent automation in regulatory affairs, helping organisations stay ahead of change rather than react to it.
You can read more about how we use Flinn AI as part of our Regulatus+ offering here: Regulatus + - Regulatory Compliance Support Tools
